Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A

Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A

SSZSE:301290
24.50
CNY
-0.52
(-2.08%)
0.74EPS
38.03P/E
2.87BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.05
1.22
4.07
2.31
2.95
5.32
5.43
5.5
5.95
5.74
4.33
4.38
3.88
4.39
Basic EPS, GAAP
0.17
0.21
0.78
0.3
0.43
1.02
0.87
1.17
1.47
1.33
0.97
0.98
-0.38
0.75
Free Cash Flow per Basic Share
0.03
0.1
-0.38
-0.14
0.57
0.87
0.58
1.3
0.9
0.26
0.52
0.11
0.38
- -
Dividend per Share
0.03
0.03
0.04
0.14
0.5
0.34
0.05
0.03
- -
- -
0.5
0.6
0.61
0.33
Book Value per Share
0.4
0.61
1.11
2.67
2.62
6.33
11.64
12.99
14.46
21.87
22.35
22.43
21.44
21.53
Tangible Book Value per Share
0.4
0.61
1.11
2.65
2.59
-0.85
-0.95
4.05
5.71
15.29
15.9
16.24
16.45
11.26
Basic Weighted Avg Shares
50
50
30
34
38
49
54
68
75
77
100
99
100
99
Sales/Revenue/Turnover
52
61
122
79
111
259
296
374
446
442
434
435
387
434
Operating Margin (%)
26.74
27.34
26.5
18.67
16.84
24.98
20.56
26
28.85
26.09
20.39
19.44
13.96
14.44
Depreciation Expense
1
- -
- -
- -
- -
7
8
23
30
36
39
43
42
- -
Net Income, GAAP
8
11
23
10
16
50
47
80
110
103
97
97
-38
74
Effective Tax Rate (%)
25.55
25.29
25.21
29.07
28.36
20.26
18.13
16.05
14.52
13.44
14.68
15.79
- -
15.37
Profit Margin (%)
16.13
17.53
19.16
12.99
14.56
19.17
16.03
21.29
24.69
23.19
22.42
22.37
-9.79
17.18
Working Capital
18
29
52
114
91
- -
-69
231
271
1,324
1,330
1,214
1,224
1,040
LT Debt
- -
- -
- -
- -
- -
55
20
1
1
- -
- -
2
2
311
Total Equity
20
30
55
138
135
326
645
986
1,097
2,204
2,246
2,254
2,155
2,197
Return on Invested Capital (%)
- -
23.78
32.45
7.99
11.72
20.02
9.81
10.26
10.87
6.19
4.46
4.29
- -
2.96
Return on Capital (%)
- -
28.73
37.94
10.27
12.14
20.89
11.91
11.44
10.53
6.14
4.25
4.33
- -
3.16
Return on Common Equity (%)
- -
42.68
54.27
10.83
12.23
22.22
9.96
9.9
10.69
6.26
4.39
4.34
-1.73
3.4

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
113
108
123
LT Borrowings
- -
- -
310
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
100
100
100
Market Capitalization
2,667
2,730
2,875

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,468
1,457
1,552
Cash, Cash Equivalents & STI
1,247
1,252
1,045
Accounts Receivable, Net
91
77
116
Inventories
115
117
342
Total Current Liabilities
218
206
512
Payables & Accruals
- -
- -
- -
ST Debt
113
108
123
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
54.96%
21.99%
-4.38%
Free Cash Flow
-10.39%
48.51%
260.93%
Net Income, GAAP
16.03%
-22.52%
-138.94%
Sales/Revenue/Turnover
18.56%
1.15%
-11.02%
Total Cash Common Dividend
- -
- -
1.39%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
92
122
102
119
435
2025
78
105
- -
104
387
2026
90
90
149
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.2
0.28
0.18
0.32
0.98
2025
0.12
0.18
- -
0.15
-0.38
2026
0.18
0.16
0.26
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.59
0.02
- -
0.6
2025
- -
0.6
- -
- -
0.61
2026
0.01
0.3
0.02
- -
- -

Company Description

CEO
Jian Gang Wei
Full Time Employees
727
Sector
Health technology
Industry
Medical specialties
Address
Changzhou China
IPO Date
Nov 30, 2022
Website
dx-med.com
Business
Jiangsu Canopus Wisdom Medical Technology Co., Ltd. is a China-based medical technology company that researches, develops, manufactures, and markets intelligent medical devices, healthcare information systems, and clinical healthcare solutions. The company operates through four core business segments: Smart Medical Equipment, Clinical Information Systems, Medical Consumables, and Healthcare Technical Services. Its comprehensive product and service portfolio includes multi-parameter patient monitoring systems and telemetry monitoring stations; intelligent infusion and precision syringe pumps; digital ward management terminals and smart nursing communication systems; clinical diagnostic apparatus and telemedicine workstations; rehabilitation assistive equipment and physiological monitoring devices; specialized disposable clinical consumables and sensor accessories; and cloud-based hospital information platforms, medical IoT integration software, and remote health management solutions. Jiangsu Canopus Wisdom Medical Technology Co., Ltd. serves a broad customer base comprising tertiary and general hospitals, specialized clinics, emergency medical centers, community healthcare institutions, and rehabilitation centers across domestic markets in China as well as international markets in Southeast Asia, Europe, the Middle East, and Latin America. Founded in Jiangsu Province, China, where it maintains its corporate headquarters, the company operates advanced research and development facilities, modern automated manufacturing centers, and specialized regional sales and service subsidiaries. In recent developments, the company has expanded its strategic focus on artificial intelligence-powered diagnostic integration and digital hospital infrastructure; formed strategic research and development alliances with leading academic medical centers and tertiary hospitals; launched next-generation AI-integrated smart ward solutions and high-precision ambulatory monitoring systems; broadened its overseas regulatory certifications and international distribution networks; and completed operational upgrades across its intelligent manufacturing facilities to scale production capacity and enhance supply chain efficiency.